Page 1 of Clinical Trials for "Peritoneal Neoplasms", 390 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Quality of Life Questionnaire for Pediatric Patients Undergoing Peritoneal Perfusion
Last Updated: January 9, 2012
Condition(s): Peritoneal Neoplasms
2
Completed
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Last Updated: April 13, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
3
Completed
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Last Updated: April 7, 2010
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
4
Recruiting
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Last Updated: May 2, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms
5
Completed
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Last Updated: January 24, 2007
Condition(s): Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
6
Terminated
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Last Updated: April 6, 2012
Condition(s): Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
7
Completed
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Last Updated: February 23, 2012
Condition(s): Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer
8
Active, not recruiting
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Last Updated: May 2, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms
9
Completed
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire
Last Updated: February 24, 2011
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
10
Completed
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis
Last Updated: March 3, 2008
Condition(s): Peritoneal Neoplasms; Stomach Neoplasms
11
Terminated
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Last Updated: March 9, 2012
Condition(s): Ovarian Cancer; Peritoneal Neoplasms
12
Completed
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
Last Updated: September 29, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
13
Completed
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
Last Updated: November 7, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
14
Completed
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Last Updated: February 28, 2011
Condition(s): Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
15
Completed
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Last Updated: May 17, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
16
Completed
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Last Updated: July 7, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
17
Recruiting
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Last Updated: January 30, 2012
Condition(s): Breast Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
18
Terminated
A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Last Updated: May 29, 2009
Condition(s): Peritoneal Neoplasms
19
Completed
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Last Updated: March 29, 2012
Condition(s): Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
20
Not yet recruiting
Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC
Last Updated: October 19, 2010
Condition(s): Peritoneal Neoplasms; Echocardiography Guided Fluid Management

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Peritoneal+Neoplasms%22

Page 1 of Clinical Trials for "Peritoneal Neoplasms", 390 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About